Complete androgen blockade for the treatment of prostate cancer.
D000135:Acid Phosphatase / Q000097:blood; D000315:Adrenalectomy; D000726:Androgen Antagonists / Q000627:therapeutic use*; D000728:Androgens / Q000096:biosynthesis / Q000097:blood; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004967:Estrogens / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D000726:Androgen Antagonists; D000728:Androgens; D000970:Antineoplastic Agents; D004967:Estrogens; D007987:Gonadotropin-Releasing Hormone; D000135:Acid Phosphatase